tiprankstipranks
Trending News
More News >

Doseology Settles Debt with Share Issuance Strategy

Story Highlights
Doseology Settles Debt with Share Issuance Strategy

Elevate Your Investing Strategy:

The latest update is out from Doseology Sciences, Inc. ( (TSE:MOOD) ).

Doseology Sciences Inc. has completed a debt settlement by issuing 100,000 common shares at $0.165 per share to settle $16,500 of a $39,000 total debt for past consulting services. The remaining $22,500 will be paid in cash. This strategic move helps Doseology manage its financial obligations while maintaining its focus on enhancing its market position and delivering value to its stakeholders.

More about Doseology Sciences, Inc.

Doseology Sciences Inc. specializes in premium functional mushroom supplements that are science-backed and formulated by health experts. The company focuses on optimizing wellness through high-purity liquid format mushroom supplements for faster absorption.

YTD Price Performance: -30.0%

Average Trading Volume: 6,180

Technical Sentiment Consensus Rating: Buy

Current Market Cap: C$596.1K

For an in-depth examination of MOOD stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1